Breaking News Instant updates and real-time market news.

SFLY

Shutterfly

$50.68

0.11 (0.22%)

, WAGE

WageWorks

$74.25

0.95 (1.30%)

10:22
11/30/16
11/30
10:22
11/30/16
10:22

On The Fly: Top five analyst initiations

Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Shutterfly (SFLY) initiated with a Buy at Aegis. 2. WageWorks (WAGE) initiated with a Buy at Chardan. 3. BorgWarner (BWA) initiated with a Buy at Jefferies. 4. Advaxis (ADXS) initiated with a Buy at Cantor. 5. Xtant (XTNT) initiated with a Buy at Aegis. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

SFLY

Shutterfly

$50.68

0.11 (0.22%)

WAGE

WageWorks

$74.25

0.95 (1.30%)

BWA

BorgWarner

$35.69

1.23 (3.57%)

ADXS

Advaxis

$8.56

-0.34 (-3.82%)

XTNT

Xtant

$0.56

0.0689 (13.96%)

  • 06

    Dec

  • 10

    Jan

SFLY Shutterfly
$50.68

0.11 (0.22%)

10/27/16
AXIO
10/27/16
UPGRADE
AXIO
Buy
Shutterfly upgraded to Buy from Hold at Axiom
10/27/16
10/27/16
UPGRADE
Target $52

Buy
Shutterfly upgraded to Buy, share are oversold, says Axiom
As previously reported, Axiom upgraded Shutterfly (SFLY) to Buy from Hol with a $52 price target. Analyst Victor Anthony said shares have been punished following the launch of Amazon Prints in late September. He believes the near-term impact from Amazon's service on Shutterfly's revenues and profits, particularly for the critical 4Q holiday season, should be muted. Anthony said Shutterfly reported solid Q3 results with the core brand growing in the double-digits and gross margins at both the Consumer and Enterprise business expanded. He views shares as very "cheap" given its leadership position, capital returns, and growing cash flow.
10/27/16
BARD
10/27/16
NO CHANGE
Target $59
BARD
Outperform
Shutterfly results should ease competitive concerns, says Baird
Baird analyst Colin Sebastian said Shutterfly reported solid Q3 results and showed no signs of competitive pressure. The analyst noted the outperformance of its Enterprise and Shutterfly-branded consumer growth and with little competitive pressure, it should alleviate investors concerns. Sebastian reiterated his Outperform rating and $59 price target on Shutterfly shares.
11/30/16
AGIS
11/30/16
INITIATION
Target $62
AGIS
Buy
Shutterfly initiated with a Buy at Aegis
Aegis analyst Victor Anthony initiated Shutterfly with a Buy and a $62 price target.
WAGE WageWorks
$74.25

0.95 (1.30%)

11/02/16
STFL
11/02/16
NO CHANGE
STFL
WageWorks acquisition positive, says Stifel
After WageWorks 9WAGE) announced the acquisition of ADP's (ADP) consumer directed benefits and COBRA business., Stifel analyst David Grossman says that synergies could allow WageWorks to double the margins of the acquired entity. The analyst keeps a $69 price target and a Buy rating on the shares.
06/09/16
STFL
06/09/16
NO CHANGE
STFL
WageWorks price target raised to $69 from $59 at Stifel
After meeting with WageWorks' management, Stifel thinks that the company's 2017 outlook is becoming more certain. The firm says that the company is benefiting from "stronger than normal midyear starts" and should get a boost from its deal with the Office of Personnel Management, which starts September 1. Stifel keeps a Buy rating on the shares.
11/30/16
CHDN
11/30/16
INITIATION
Target $86
CHDN
Buy
WageWorks initiated with a Buy at Chardan
Chardan analyst Steven Wardell initiated WageWorks with a Buy and an $86 price target.
BWA BorgWarner
$35.69

1.23 (3.57%)

11/30/16
JEFF
11/30/16
INITIATION
Target $43
JEFF
Buy
BorgWarner initiated with a Buy at Jefferies
Jefferies analyst David Kelley initiated BorgWarner with a Buy rating, saying turbochargers remain a growth driver while the company's new technology acquisition and mix shift position it for penetration in hybrid/electric vehicles. Kelley sets a $43 price target on BorgWarner shares.
11/09/16
11/09/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan (JPM) downgraded to Neutral from Outperform at Baird with analyst David George noting the stock's outperformance and the higher re-rating of its valuation multiple. 2. GoPro (GPRO) downgraded to Neutral from Outperform at Wedbush, to Market Perform from Outperform at Raymond James, and to Sell from Neutral at Dougherty. 3. Universal Health (UHS) downgraded to Neutral from Buy at BofA/Merrill, to Neutral from Buy at Mizuho, and to Market Perform from Outperform at Avondale. 4. Globus Medical (GMED) downgraded to Market Perform from Outperform at JMP Securities, to Perform from Outperform at Oppenheimer, and to Market Perform from Outperform at William Blair. 5. Delphi (DLPH) and Magna (MGA) were downgraded to Underperform from Buy at BofA/Merrill while the firm downgraded Lear (LEA), American Axle (AXL), Adient (ADNT), and BorgWarner (BWA) to Underperform from Neutral. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/22/16
BREN
11/22/16
INITIATION
Target $28
BREN
Sell
BorgWarner initiated with a Sell at Berenberg
Target $28.
11/09/16
BOFA
11/09/16
DOWNGRADE
Target $29
BOFA
Underperform
BorgWarner downgraded on Trump win, NAFTA may lose, says BofA/Merrill
As previously reported, BofA/Merrill downgraded BorgWarner to Underperform from Neutral and cut its price target to $29 from $39. Analyst John Murphy said the Trump victory and Republican sweep of Congress will result in a "significant" disruption in auto volumes given Trump's goal to renegotiate NAFTA and other relationships. Murphy said a massive restructure or elimination of NAFTA would have "far reaching" repercussions on the US auto industry, potentially freezing close to 5M vehicles imported/exported between the US, Canada, and Mexico.
ADXS Advaxis
$8.56

-0.34 (-3.82%)

12/16/15
JANY
12/16/15
INITIATION
Target $22
JANY
Buy
Advaxis coverage resumed with a Buy at Janney Capital
Target $22.
05/17/16
JANY
05/17/16
NO CHANGE
Target $22
JANY
Buy
Aduro study failure has limited read-through to Advaxis, says Janney Capital
Janney Capital analyst Roy Buchanan said the failure of a trial Aduro Biotech's (ADRO) listeria-based immunotherapy candidate in advanced pancreatic cancer should have limited read-through to Advaxis' (ADXS) own listeria-based immunotherapy program. The lead indications for Advaxis, including HPV-driven cervical cancer, have good rationale that the HPV is causative, Buchanan tells investors. The analyst keeps a Buy rating and $22 fair value estimate on Advaxis shares.
11/30/16
CANT
11/30/16
INITIATION
Target $19
CANT
Buy
Advaxis initiated with a Buy at Cantor
Cantor analyst Mara Goldstein initiated Advaxis with a Buy and a $19 price target.
XTNT Xtant
$0.56

0.0689 (13.96%)

11/30/16
AGIS
11/30/16
INITIATION
Target $3.5
AGIS
Buy
Xtant initiated with a Buy at Aegis
Aegis analyst Jason Wittes initiated Xtant with a Buy and a $3.50 price target.

TODAY'S FREE FLY STORIES

SBUX

Starbucks

$57.57

0.03 (0.05%)

19:34
02/22/17
02/22
19:34
02/22/17
19:34
Hot Stocks
Market researcher: Starbucks consumer perception dips after refugee hiring news »

Market researcher YouGov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

LB

Labarge

$58.13

0.43 (0.75%)

19:33
02/22/17
02/22
19:33
02/22/17
19:33
Hot Stocks
L Brands sees Q1 comps down high-single to low-double digits »

Sees Q1 Go-Forwards comps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

LB

Labarge

$58.13

0.43 (0.75%)

19:32
02/22/17
02/22
19:32
02/22/17
19:32
Hot Stocks
L Brands sees FY17 comps down low-single digits »

Sees FY17 Go-Forward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

F

Ford

$12.67

-0.02 (-0.16%)

19:30
02/22/17
02/22
19:30
02/22/17
19:30
Conference/Events
Ford to host sales conference call »

Ford U.S. Sales Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

GTLS

Chart Industries

$38.51

-1.21 (-3.05%)

19:27
02/22/17
02/22
19:27
02/22/17
19:27
Hot Stocks
Chart Industries CEO Samuel Thomas named executive chairman »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$273.51

-3.88 (-1.40%)

19:24
02/22/17
02/22
19:24
02/22/17
19:24
Periodicals
SolarCity leased with risky homeowners, has ties to foreclosure cases, NYT says »

In "dozens of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

PRU

Prudential

$110.50

-0.72 (-0.65%)

, WFC

Wells Fargo

$58.36

0.11 (0.19%)

19:16
02/22/17
02/22
19:16
02/22/17
19:16
Hot Stocks
Prudential says could seek compensation from Wells Fargo over MyTerm products »

Prudential (PRU) stated…

PRU

Prudential

$110.50

-0.72 (-0.65%)

WFC

Wells Fargo

$58.36

0.11 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

  • 13

    Apr

  • 06

    Jun

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

PSA

Public Storage

$226.24

-1.49 (-0.65%)

19:15
02/22/17
02/22
19:15
02/22/17
19:15
Earnings
Public Storage reports Q4 core FFO $2.65, consensus $1.89 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CS

Credit Suisse

$15.35

-0.13 (-0.84%)

19:10
02/22/17
02/22
19:10
02/22/17
19:10
Periodicals
Credit Suisse probed for potentially aiding tax evasion, WSJ says »

Less than three years…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

LZB

La-Z-Boy

$28.40

-1.05 (-3.57%)

19:09
02/22/17
02/22
19:09
02/22/17
19:09
Downgrade
La-Z-Boy rating change  »

La-Z-Boy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CLD

Cloud Peak

$5.68

-0.19 (-3.24%)

19:06
02/22/17
02/22
19:06
02/22/17
19:06
Syndicate
Cloud Peak 13.5M share Spot Secondary priced at $5.10 »

Credit Suisse, JPMorgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SNAP

Snap Inc

18:47
02/22/17
02/22
18:47
02/22/17
18:47
Periodicals
Snap Inc nears $200M ad deal, NY Post says »

Snap Inc is close to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

SBLK

Star Bulk Carriers

$9.59

0.29 (3.12%)

18:40
02/22/17
02/22
18:40
02/22/17
18:40
Earnings
Star Bulk Carriers reports Q4 EPS (29c), consensus (28c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 22

    Mar

C

Citi

$60.62

0.07 (0.12%)

18:35
02/22/17
02/22
18:35
02/22/17
18:35
Periodicals
Citi forms regulatory affairs team in D.C., Bloomberg says »

Citi is forming a global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

PRAH

PRA Health

$59.98

-0.71 (-1.17%)

18:34
02/22/17
02/22
18:34
02/22/17
18:34
Earnings
PRA Health sees FY17 EPS $3.08-$3.18, consensus $2.96 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

FGL

Fidelity & Guaranty Life

$26.30

-0.1 (-0.38%)

, ATH

Athene Holding

$51.45

0.38 (0.74%)

18:32
02/22/17
02/22
18:32
02/22/17
18:32
Periodicals
Fidelity & Guaranty Life revives sale process, Insurance Insider says »

Fidelity & Guaranty…

FGL

Fidelity & Guaranty Life

$26.30

-0.1 (-0.38%)

ATH

Athene Holding

$51.45

0.38 (0.74%)

APO

Apollo Global

$22.25

0.05 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

PRAH

PRA Health

$59.98

-0.71 (-1.17%)

18:31
02/22/17
02/22
18:31
02/22/17
18:31
Earnings
PRA Health sees Q1 EPS 57c-62c, consensus 67c »

Sees Q1 service revenues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

NBR

Nabors Industries

$15.44

0.01 (0.06%)

18:30
02/22/17
02/22
18:30
02/22/17
18:30
Earnings
Nabors Industries reports Q4 EPS ($1.17) with items »

Q4 EPS includes 87c in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

AXGN

AxoGen

$10.50

-0.1 (-0.94%)

18:28
02/22/17
02/22
18:28
02/22/17
18:28
Earnings
AxoGen reiterates FY17 revenue growth view of at least 40% »

Management reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 14

    Mar

  • 21

    Mar

AXGN

AxoGen

$10.50

-0.1 (-0.94%)

18:26
02/22/17
02/22
18:26
02/22/17
18:26
Earnings
AxoGen reports Q4 EPS (10c), consensus (9c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 14

    Mar

  • 21

    Mar

GEN

Genesis Healthcare

$3.83

-0.05 (-1.29%)

18:26
02/22/17
02/22
18:26
02/22/17
18:26
Earnings
Genesis Healthcare sees FY17 revenue $5.4B-$5.6B, consensus $5.64B »

Sees FY17 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

URRE

Uranium Resources

$1.91

-0.06 (-3.05%)

18:25
02/22/17
02/22
18:25
02/22/17
18:25
Hot Stocks
Uranium Resources reports favorable lithium concentrations at Columbus Basin »

Uranium Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEN

Genesis Healthcare

$3.83

-0.05 (-1.29%)

18:24
02/22/17
02/22
18:24
02/22/17
18:24
Earnings
Genesis Healthcare reports Q4 revenue $1.4B, consensus $1.4B »

Reports Q4 net income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

MCRI

Monarch Casino

$23.98

-0.22 (-0.91%)

18:22
02/22/17
02/22
18:22
02/22/17
18:22
Earnings
Monarch Casino reports Q4 EPS 36c, consensus 33c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBMX

CombiMatrix

$4.10

-0.1 (-2.38%)

, UCTT

Ultra Clean

$12.58

0.2 (1.62%)

18:22
02/22/17
02/22
18:22
02/22/17
18:22
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

CBMX

CombiMatrix

$4.10

-0.1 (-2.38%)

UCTT

Ultra Clean

$12.58

0.2 (1.62%)

SQ

Square

$15.04

0.41 (2.80%)

CTRP

Ctrip.com

$47.59

0.53 (1.13%)

TSLA

Tesla

$273.51

-3.88 (-1.40%)

BLCM

Bellicum Pharmaceuticals

$12.79

-0.6 (-4.48%)

LB

Labarge

$58.13

0.43 (0.75%)

TSRA

Tessera

$44.65

-0.2 (-0.45%)

ARRS

ARRIS

$30.70

0.75 (2.50%)

JACK

Jack in the Box

$103.60

-3.77 (-3.51%)

SAM

Boston Beer

$166.85

-1.9 (-1.13%)

ELGX

Endologix

$6.53

0.04 (0.62%)

CSGP

CoStar Group

$210.02

-1.35 (-0.64%)

FMI

Foundation Medicine

$23.85

-0.6 (-2.45%)

AXGN

AxoGen

$10.50

-0.1 (-0.94%)

CLD

Cloud Peak

$5.68

-0.19 (-3.24%)

NGD

New Gold

$3.04

-0.08 (-2.56%)

NVDA

NVIDIA

$110.76

-0.31 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 05

    Mar

  • 14

    Mar

  • 16

    Mar

  • 16

    Mar

  • 21

    Mar

  • 21

    Mar

  • 22

    Mar

  • 22

    Mar

  • 23

    Mar

  • 23

    Mar

  • 27

    Mar

  • 27

    Mar

  • 28

    Mar

  • 23

    Feb

  • 23

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.